Enoxaparin Sodium Injection
Product Images NDC 0548-5607

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 0548-5607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Stock No.: 5601 (principal Panel) (Carton 5601a)

This is a description of Enoxaparin Sodium Injection, a medication used for subcutaneous injection. It comes in a single dose syringe with 30 mg/0.3 mL strength and has automated safety devices. The brand names mentioned are AxoNLY and RxonLY.*

FDA Label Image

Carton Stock No.: 5601 (Carton 5601b)

This is a package of Enoxaparin sodium injection containing 10 single-dose syringes with a strength of 30 mg. It is meant for subcutaneous injection and comes with instructions.*

FDA Label Image

Carton Stock No.: 5602 (principal Display) (Carton 5602a)

This is a description of Enoxaparin sodium injection in a single dose syringe with an automatic safety device. The injection contains 40 mg/0.4 mL of Enoxaparin sodium and is intended for subcutaneous injection.*

FDA Label Image

Carton Stock No.: 5602 (Carton 5602b)

FDA Label Image

Carton Stock No.: 5603 (principal Panel) (Carton 5603a)

This is a product description for Enoxaparin Sodium Injection, which is available in a dosage strength of 60 mg/0.6 mL. It is indicated for subcutaneous injection and is available in both single-dose syringes and multi-dose vials. The remaining text is not readable.*

FDA Label Image

Carton Stock No.: 5603 (Carton 5603b)

This is a description of a medication called enoxaparin sodium injection, which comes in single-dose syringes of 60mg. The price of this product is £261.05 and it is used for subcutaneous injection. The text includes dosage instructions and warnings to keep it out of reach of children.*

FDA Label Image

Carton Stock No.: 5604 (principal Panel) (Carton 5604a)

This is a package of Enoxaparin Sodium Injection containing 80 mg/0.8 mL in 50 single-dose syringes with automated safety device for subcutaneous injection. The text is partially cut off, and there are some errors, but the product name, dosage, administration, and safety information are discernible.*

FDA Label Image

Carton Stock No.: 5604 (Carton 5604b)

FDA Label Image

Carton Stock No.: 5605 (principal Panel) (Carton 5605a)

FDA Label Image

Carton Stock No.: 5605 (Carton 5605b)

This is a description of a medication called Enoxaparin Sodium Injection, which comes in a package of 10 single-dose syringes that each contain 100 mg of the medication. It is meant for subcutaneous injection. The text also includes some numbers and a warning about storage temperature. There is some garbled text at the beginning that is not readable or available.*

FDA Label Image

Carton Stock No.: 5606 (principal Panel) (Carton 5606a)

ENOXAPARIN SODIUM INJECTION is a medication administered through subcutaneous injection using single dose syringes with an automated safety device. Each syringe contains 120 mg of medication in 0.8 mL solution. This information is intended for medical professionals only.*

FDA Label Image

Carton Stock No.: 5606 (Carton 5606b)

This is a description of Enoxaparin Sodium Injection, which comes in 10 single dose syringes of 120mg each. Enoxaparin Sodium is to be injected subcutaneously and is used for the prevention of blood clots. The text also includes some warnings and precautions for the proper use of the medication.*

FDA Label Image

Carton Stock No.: 5607 (principal Panel) (Carton 5607a)

ENOXAPARIN SODIUM INJECTION is a prescription medication available in single-dose syringes with automatic safety devices, containing 150mg/mL of the active ingredient. It is intended for use as a subcutaneous injection.*

FDA Label Image

Carton Stock No.: 5607 (Carton 5607b)

FDA Label Image

Carton Stock No.: 5608 (principal Panel) (Carton 5608)

FDA Label Image

Instructions 1 (Enoxaparin 00)

FDA Label Image

Instructions 2 (Enoxaparin 01)

FDA Label Image

Instructions 3 (Enoxaparin 02)

FDA Label Image

Instructions 4 (Enoxaparin 03)

FDA Label Image

Instructions 5 (Enoxaparin 04)

FDA Label Image

Instructions 6 (Enoxaparin 05)

FDA Label Image

Chemical Structure (Enoxaparin 06)

FDA Label Image

Chemical Structure (Enoxaparin 07)

FDA Label Image

Figure 1 (Enoxaparin 08)

The given text includes a table that possibly presents a study related to risk reduction due to some medication or treatment for patients with different medical conditions. The presented variables include patient's sex, age, infarction location, diabetes, prior Mi, fibrinolytic agents, time to treatment, and other parameters. The relative risk reduction for each subgroup is given in percentages. The study compares two different types of fibrinolytic agents and shows that UFH is a better option for risk reduction.*

FDA Label Image

Figure 2 (Enoxaparin 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.